Decoding the Science of Life
Closed-loop stimulation has been framed as a modelling problem — understand the dynamics well enough…
NeuroAI is used to describe everything from brain-inspired chip design to neural decoding. Until the…
Announced production capacity now runs an order of magnitude ahead of units doing paid work.…
FDA has approved two zanidatamab-hrii, or Ziihera, treatment approaches for adults with unresectable locally advanced or metastatic HER2-positive gastric, gastroesophageal-junction…
Capricor Therapeutics announced on August 24 that FDA extended the target action date for its Biologics License Application for deramiocel,…
The FDA’s accelerated approval of Genglycos is a landmark for patients with glycogen storage disease type Ia, a rare inherited…
Oncolytics Biotech has secured FDA written feedback that could make the development path for pelareorep in metastatic colorectal cancer more…
Argenx has reported positive Phase 3 results for VYVGART Hytrulo in autoimmune myositis, a heterogeneous group of rare inflammatory diseases…
As consumer health agents and biomedical AI models accelerate, the central economic and ethical question facing the industry is no…
AbelZeta Pharma has received FDA clearance to begin U.S. clinical development of Prizlon-cel, an anti-CD20/CD19 bispecific CAR-T therapy for relapsed…
The FDA’s accelerated approval of Bristol Myers Squibb’s Zenbexus gives multiple-myeloma treatment a new class of medicine and creates an…
The U.S. Food and Drug Administration has cleared Xilio Therapeutics to begin human testing of XTX501, a bispecific PD-1 and…
In a stark reminder of the immense logistical complexities surrounding radiopharmaceuticals, the U.S. Food and Drug Administration (FDA) has issued…
The battle for dominance in the lucrative obesity drug market is entering a new and aggressive phase. Eli Lilly has…
